Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes

Kieren Mather, Bahram Mirzamohammadi, Amale Lteif, Helmut O. Steinberg, Alain D. Baron

Research output: Contribution to journalArticle

167 Citations (Scopus)

Abstract

Endothelium-dependent vasodilation is impaired in clinical states of insulin resistance such as obesity and type 2 diabetes. Individuals who have hyperinsulinemic insulin resistance have relatively elevated circulating levels of endothelin (ET)-1, suggesting that ET-1 may be important in the endothelial dysfunction and alterations of vascular tone in these conditions. In 8 lean subjects, 12 nondiabetic obese subjects, and 8 subjects with type 2 diabetes, we measured basal and methacholine-stimulated rates of leg blood flow (LBF) and total serum nitrates (NOx) before and after the intrafemoral arterial administration of BQ123, a specific blocker of ETA receptors. BQ123 produced significant vasodilation in the obese and type 2 diabetic subjects (leg vascular resistance = mean arterial pressure/LBF fell by 34 and 36%; P < 0.005) but not in the lean subjects (13%; P = NS, P = 0.018 comparing all groups). ETA blockade did not change basal NOx flux (NOx*LBF). This suggests increased basal ET-1 constrictor tone among obese and type 2 diabetic subjects. BQ123 corrected the baseline defect in endothelium-dependent vasodilation seen in obese and type 2 diabetic subjects, suggesting an important contribution of ET-1 to endothelial dysfunction in these subjects. In contrast to basal conditions, stimulated NOx flux was augmented by BQ123 in obese and type 2 diabetic subjects but not in L subjects (P = 0.04), suggesting a combined effect of ETA blockade to reduce constrictor tone and augment dilator tone. Endothelin seems to contribute to endothelial dysfunction and the regulation of vascular tone in human obesity and type 2 diabetes.

Original languageEnglish
Pages (from-to)3517-3523
Number of pages7
JournalDiabetes
Volume51
Issue number12
StatePublished - Dec 1 2002

Fingerprint

Endothelins
Endothelin-1
Type 2 Diabetes Mellitus
Blood Vessels
Leg
Obesity
Vasodilation
Endothelium
Insulin Resistance
Methacholine Chloride
Vascular Resistance
Nitrates
Arterial Pressure
cyclo(Trp-Asp-Pro-Val-Leu)
Serum

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. / Mather, Kieren; Mirzamohammadi, Bahram; Lteif, Amale; Steinberg, Helmut O.; Baron, Alain D.

In: Diabetes, Vol. 51, No. 12, 01.12.2002, p. 3517-3523.

Research output: Contribution to journalArticle

Mather, Kieren ; Mirzamohammadi, Bahram ; Lteif, Amale ; Steinberg, Helmut O. ; Baron, Alain D. / Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. In: Diabetes. 2002 ; Vol. 51, No. 12. pp. 3517-3523.
@article{50d08ec5a24c4379a5bac0925df384de,
title = "Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes",
abstract = "Endothelium-dependent vasodilation is impaired in clinical states of insulin resistance such as obesity and type 2 diabetes. Individuals who have hyperinsulinemic insulin resistance have relatively elevated circulating levels of endothelin (ET)-1, suggesting that ET-1 may be important in the endothelial dysfunction and alterations of vascular tone in these conditions. In 8 lean subjects, 12 nondiabetic obese subjects, and 8 subjects with type 2 diabetes, we measured basal and methacholine-stimulated rates of leg blood flow (LBF) and total serum nitrates (NOx) before and after the intrafemoral arterial administration of BQ123, a specific blocker of ETA receptors. BQ123 produced significant vasodilation in the obese and type 2 diabetic subjects (leg vascular resistance = mean arterial pressure/LBF fell by 34 and 36{\%}; P < 0.005) but not in the lean subjects (13{\%}; P = NS, P = 0.018 comparing all groups). ETA blockade did not change basal NOx flux (NOx*LBF). This suggests increased basal ET-1 constrictor tone among obese and type 2 diabetic subjects. BQ123 corrected the baseline defect in endothelium-dependent vasodilation seen in obese and type 2 diabetic subjects, suggesting an important contribution of ET-1 to endothelial dysfunction in these subjects. In contrast to basal conditions, stimulated NOx flux was augmented by BQ123 in obese and type 2 diabetic subjects but not in L subjects (P = 0.04), suggesting a combined effect of ETA blockade to reduce constrictor tone and augment dilator tone. Endothelin seems to contribute to endothelial dysfunction and the regulation of vascular tone in human obesity and type 2 diabetes.",
author = "Kieren Mather and Bahram Mirzamohammadi and Amale Lteif and Steinberg, {Helmut O.} and Baron, {Alain D.}",
year = "2002",
month = "12",
day = "1",
language = "English",
volume = "51",
pages = "3517--3523",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "12",

}

TY - JOUR

T1 - Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes

AU - Mather, Kieren

AU - Mirzamohammadi, Bahram

AU - Lteif, Amale

AU - Steinberg, Helmut O.

AU - Baron, Alain D.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Endothelium-dependent vasodilation is impaired in clinical states of insulin resistance such as obesity and type 2 diabetes. Individuals who have hyperinsulinemic insulin resistance have relatively elevated circulating levels of endothelin (ET)-1, suggesting that ET-1 may be important in the endothelial dysfunction and alterations of vascular tone in these conditions. In 8 lean subjects, 12 nondiabetic obese subjects, and 8 subjects with type 2 diabetes, we measured basal and methacholine-stimulated rates of leg blood flow (LBF) and total serum nitrates (NOx) before and after the intrafemoral arterial administration of BQ123, a specific blocker of ETA receptors. BQ123 produced significant vasodilation in the obese and type 2 diabetic subjects (leg vascular resistance = mean arterial pressure/LBF fell by 34 and 36%; P < 0.005) but not in the lean subjects (13%; P = NS, P = 0.018 comparing all groups). ETA blockade did not change basal NOx flux (NOx*LBF). This suggests increased basal ET-1 constrictor tone among obese and type 2 diabetic subjects. BQ123 corrected the baseline defect in endothelium-dependent vasodilation seen in obese and type 2 diabetic subjects, suggesting an important contribution of ET-1 to endothelial dysfunction in these subjects. In contrast to basal conditions, stimulated NOx flux was augmented by BQ123 in obese and type 2 diabetic subjects but not in L subjects (P = 0.04), suggesting a combined effect of ETA blockade to reduce constrictor tone and augment dilator tone. Endothelin seems to contribute to endothelial dysfunction and the regulation of vascular tone in human obesity and type 2 diabetes.

AB - Endothelium-dependent vasodilation is impaired in clinical states of insulin resistance such as obesity and type 2 diabetes. Individuals who have hyperinsulinemic insulin resistance have relatively elevated circulating levels of endothelin (ET)-1, suggesting that ET-1 may be important in the endothelial dysfunction and alterations of vascular tone in these conditions. In 8 lean subjects, 12 nondiabetic obese subjects, and 8 subjects with type 2 diabetes, we measured basal and methacholine-stimulated rates of leg blood flow (LBF) and total serum nitrates (NOx) before and after the intrafemoral arterial administration of BQ123, a specific blocker of ETA receptors. BQ123 produced significant vasodilation in the obese and type 2 diabetic subjects (leg vascular resistance = mean arterial pressure/LBF fell by 34 and 36%; P < 0.005) but not in the lean subjects (13%; P = NS, P = 0.018 comparing all groups). ETA blockade did not change basal NOx flux (NOx*LBF). This suggests increased basal ET-1 constrictor tone among obese and type 2 diabetic subjects. BQ123 corrected the baseline defect in endothelium-dependent vasodilation seen in obese and type 2 diabetic subjects, suggesting an important contribution of ET-1 to endothelial dysfunction in these subjects. In contrast to basal conditions, stimulated NOx flux was augmented by BQ123 in obese and type 2 diabetic subjects but not in L subjects (P = 0.04), suggesting a combined effect of ETA blockade to reduce constrictor tone and augment dilator tone. Endothelin seems to contribute to endothelial dysfunction and the regulation of vascular tone in human obesity and type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0036895991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036895991&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 3517

EP - 3523

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 12

ER -